The persistence of stark health inequalities in today’s world is painfully clear to see, not least in the effects of the Covid-19 pandemic and falling life expectancy in many parts of the world. How can we advance our understanding of the full extent of health inequality, what drives it, and ways to address it? The third edition of this popular book closely examines the influence of social class, gender, and race/ethnicity (among other issues) on health in the light of broad macro-political contexts. The classic behavioural, psychosocial, and material approaches to health and their embodiment within a life-course perspective are introduced but, importantly, are also re-situated within the growing understanding of the commercial and political determinants of health. Bartley and Kelly-Irving draw on extensive new evidence that shows how the chances for everyone to lead a long and healthy life depend on where power lies to control health-damaging policies and introduce health-promoting ones. Health Inequality will continue to be essential reading for students taking courses in the sociology of health and illness, social policy and welfare, health sciences, public health and epidemiology and all those interested in understanding the consequences of social inequality for health.
The introduction of anti-vascular endothelial growth factor (VEGF) agents has revolutionized therapy for a host of ocular diseases associated with leakage from normal blood vessels and pathologic blood vessel growth. Anti-VEGF Use in Ophthalmology is an all-inclusive reference designed to provide detailed, up-to-date, and clinically relevant information on the current use of anti-VEGF agents in the treatment of all ocular conditions. Drs. Jay S. Duker and Michelle C. Liang have assembled a prestigious group of contributors who pool their collective expertise in this comprehensive book. Anti-VEGF Use in Ophthalmology is split into two sections with the first providing the history of VEGF and an overview of anti-VEGF agents and different routes of drug delivery, as it is important for eye care providers to be familiar with up-to-date aspects of the medications and indications for use. The second section details the clinical uses of anti-VEGF agents in numerous ocular diseases, from the anterior segment including cornea and glaucoma to uveitis and various retinal and choroidal diseases. Each chapter in this section summarizes the disease process and utilizes high-quality ocular imaging to demonstrate the therapeutic use of the anti-VEGF agents. Some of the topics covered in Anti-VEGF Use in Ophthalmology: Neovascular Age-Related Macular Degeneration Proliferative Diabetic Retinopathy Retinal Vein Occlusion Uveitis Neovascular Glaucoma Macular Edema Retinopathy of Prematurity Corneal Disease Anti-VEGF Use in Ophthalmology combines the theory and applications of anti-VEGF agents, making it not only a great learning tool for beginners but also a useful reference tool for a wide range of eye care professionals including optometrists, residents, comprehensive ophthalmologists, as well as specialists in anterior segment, pediatrics, and vitreoretinal disease.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.